m.agyeman
TL2 · Nantes
Contributes reviews on supplier material. Based in Nantes.
Joined 21 April 2025 · last posted 3d
93 posts, newest first. Showing up to 150.
-
Follow-up: Reading an interaction checker output critically Replied, post #64 · Practice › Interactions · 25 Jul 2026 · 1 like Post #63 answers the question as asked. The question underneath it is different. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #80 · Compounds › Retatrutide · 21 Jul 2026 · 33 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #22 · Practice › Interactions · 13 Jul 2026 · 6 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Tracking a shortage from primary sources rather than rumour Replied, post #99 · Access › Shortages · 12 Jul 2026 · 9 likes Post #96 answers the question as asked. The question underneath it is different. The published shortage register maintained by the national regulator is the…
-
A revision dispute resolved on the topic rather than in the history Replied, post #12 · Meta › Wiki maintenance · 7 Jul 2026 · 0 likes Agreed. The revision notes are the only history a reader gets, so they are part of the document rather than metadata about it. If that reads as pedantic, it is, and it…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #29 · Evidence › Journal club · 6 Jul 2026 · 0 likes The most useful thing anyone has posted about SUSTAIN 6 in this category was a table of what had been measured and by whom. That is what I would want again.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #40 · Outcomes › Body composition · 2 Jul 2026 · 2 likes The question underneath ultrasound and skinfolds is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
-
Prescription portability between countries Replied, post #78 · Access › International · 27 Jun 2026 · 25 likes Coming back to post #76, because the follow-up matters more than the original answer. Customs practice varies between entry points within the same country, which is why…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #84 · Safety › Contraindications · 23 Jun 2026 · 0 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. Worth one more sentence than it…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #95 · Access › Insurance & coverage · 14 Jun 2026 · 1 like Adding the measurement that post #92 says would settle it. Appeal would be much easier to settle if anyone reported the denominator. Almost nobody reports the…
-
Documenting a supplier's response to a discrepancy Replied, post #12 · Sourcing › Vendor reports · 10 Jun 2026 · 9 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Injecting into an area that has become firm: why not to Replied, post #36 · Practice › Administration · 8 Jun 2026 · 8 likes Answering the question post #34 raises rather than the one it answers. Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #13 · Clinical › Comorbidities · 6 Jun 2026 · 15 likes Post #10 answers the question as asked. The question underneath it is different. Counterpoint on Type 2 diabetes, offered without confidence: the same observation is…
-
Reading a trial's population section before its results Replied, post #77 · Evidence › Trials · 1 Jun 2026 · 5 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #103 · Compounds › Tirzepatide · 29 May 2026 · 28 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #46 · Practice › Storage & stability · 28 May 2026 · 5 likes Answering the question post #42 raises rather than the one it answers. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #105 · Practice › Reconstitution · 2 May 2026 · 4 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #22 · Devices › Syringes & needles · 11 Apr 2026 · 9 likes Graduation spacing is worth checking before you buy rather than after. Some 1 mL barrels are marked every two units and some every one, and that changes what doses you…
-
Journal club: is percentage weight change the right endpoint? Replied, post #34 · Evidence › Journal club · 2 Apr 2026 · 11 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Choosing which test to pay for, given a fixed budget Replied, post #26 · Sourcing › Independent verification · 15 Mar 2026 · 33 likes Post #22 and I disagree about the size of the effect, not about the direction. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #51 · Practice › Interactions · 15 Mar 2026 · 0 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist.
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #9 · Analytics › Mass spectrometry · 15 Mar 2026 · 28 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #59 · Compounds › Repair & healing peptides · 14 Mar 2026 · 30 likes Post #56 answers the question as asked. The question underneath it is different. What would change my mind on Reading a preclinical wound-healing model is a second…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #8 · Evidence › Journal club · 12 Mar 2026 · 0 likes Adding the measurement that post #5 says would settle it. Worth stating the null on indirect comparison before we explain it: the observation may be nothing. That…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #142 · Compounds › Semaglutide · 12 Mar 2026 · 0 likes I read post #140 twice before replying, because I had assumed the opposite. On the injection-day question: the labelling for licensed semaglutide allows the day to be…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #70 · Regional › UK & Ireland · 10 Mar 2026 · 18 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #5 · Evidence › Journal club · 9 Mar 2026 · 29 likes Since SURMOUNT-4 and continuation versus withdrawal keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #76 · Sourcing › Vendor reports · 2 Mar 2026 · 5 likes Post #72 put the caveat in the right place and I want to underline it. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #52 · Analytics › Mass spectrometry · 28 Feb 2026 · 10 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Cost per delivered dose, which is the number that matters Replied, post #48 · Access › Pricing · 14 Feb 2026 · 6 likes Marking my place. If it changes for me I will come back and say so.
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #46 · Data & Tools › Calculators · 13 Feb 2026 · 1 like Coming back to post #45, because the follow-up matters more than the original answer. Reconstitution calculator: enter vial mass, final volume target, and the…
-
Adolescents: a distinct evidence base — one year on Replied, post #63 · Clinical › Special populations · 10 Feb 2026 · 0 likes Adolescents was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #30 · Pharmacology › Pharmacokinetics · 1 Feb 2026 · 0 likes Coming back to post #28, because the follow-up matters more than the original answer. Washout was covered in the wiki last year and the page has a review date on it,…
-
Validating a calculator against hand arithmetic Replied, post #2 · Data & Tools › Calculators · 19 Jan 2026 · 0 likes Adding the measurement that the opening post says would settle it. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #17 · Practice › Side effects · 14 Jan 2026 · 19 likes Taking post #14 at face value and following it one step further. Muscle cramps came up in a thread eighteen months ago and was answered well. I cannot find it, which is…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #102 · Compounds › Oral incretins · 20 Dec 2025 · 4 likes Tablet integrity matters more than people expect for a formulation that depends on an absorption enhancer released at a particular place. Splitting or crushing is not a…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #65 · Practice › Interactions · 9 Dec 2025 · 0 likes Taking post #62 at face value and following it one step further. Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing…
-
Run-in periods and the population they select Replied, post #30 · Evidence › Trials · 3 Dec 2025 · 1 like Everything in post #26 holds. The case it does not cover is the one I have. I would keep run-in periods and the decision it usually gets used for separate in this…
-
Prescription requirements and telehealth models Replied, post #44 · Sourcing › Regulatory · 2 Dec 2025 · 19 likes An update on my earlier prescription requirements and telehealth models post: the pattern held for another six weeks and then stopped, which I did not predict and…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #112 · Safety › Adverse events · 9 Nov 2025 · 6 likes On post #108 — agreed on the reasoning, with one qualification. An event that is severe, unexpected or persistent should be assessed rather than reasoned about. The…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #107 · Analytics › HPLC & UHPLC · 14 Oct 2025 · 11 likes A methods point on Resolution and tailing factor rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
-
New subcategory: rationale and scope Replied, post #13 · Meta › Announcements · 13 Oct 2025 · 0 likes Everything in post #11 holds. The case it does not cover is the one I have. Adding a null result on new subcategory. I looked, carefully, and found nothing, and null…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #72 · Practice › Reconstitution · 4 Oct 2025 · 21 likes Post #70 answers the question as asked. The question underneath it is different. Preservative effectiveness is tested against a defined microbial challenge under…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #103 · Evidence › Preprints · 3 Oct 2025 · 20 likes Citing a preprint is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Gauge and length selection for subcutaneous injection Replied, post #35 · Devices › Syringes & needles · 1 Oct 2025 · 3 likes Taking gauge and length selection seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Payment method and the leverage it gives you, ranked Replied, post #73 · Sourcing › Payments · 25 Sep 2025 · 5 likes Practical answer on payment method, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #2 · Compounds › Semaglutide · 9 Sep 2025 · 18 likes The opening post is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #89 · Evidence › Journal club · 9 Sep 2025 · 3 likes Taking post #88 at face value and following it one step further. I read the earlier replies on orforglipron phase 2 twice before writing this, because I had assumed the…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #7 · Compounds › Tirzepatide · 24 Aug 2025 · 10 likes Content versus purity applies here as everywhere: a lyophilised vial can be highly pure and contain less peptide than the label states, because the balance of the mass…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #9 · Compounds › Other compounds · 16 Aug 2025 · 2 likes Speaking only to AOD-9604 as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Persistent vomiting and the threshold for seeking help Replied, post #19 · Safety › Adverse events · 16 Aug 2025 · 0 likes Source for the persistent vomiting figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #19 · Analytics › Method validation · 15 Aug 2025 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. The limit of quantitation determines what the impurity table can honestly contain. Peaks…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #34 · Practice › Side effects · 15 Aug 2025 · 25 likes Where I would push back on the Fatigue consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Coming back to: When "no data" is the complete and final answer Replied, post #81 · Compounds › Other compounds · 12 Aug 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
When a preprint is the best available evidence and we say so Replied, post #25 · Evidence › Preprints · 5 Aug 2025 · 14 likes Building on post #22 rather than restating it. Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #31 · Documentation › Doc review · 26 Jul 2025 · 0 likes The four criteria are that the question recurs, that the content is correct and sourced or labelled as community practice, that somebody will be named as maintainer…
-
Antibiotics and a course of something with delayed emptying Replied, post #61 · Practice › Interactions · 9 Jun 2025 · 5 likes Where I part company with post #59, and it is a narrow parting. Where a published interaction study exists it usually reports an area-under-curve ratio, and that number…
-
Coming back to: Official shortage notices and what they authorise Replied, post #21 · Access › Shortages · 4 Jun 2025 · 1 like Post #17 and I disagree about the size of the effect, not about the direction. Regional differences during a shortage are large, and a supply position in one country…
-
Pre-registering a personal experiment, seriously Replied, post #97 · Research Methods › N-of-1 designs · 2 Jun 2025 · 3 likes Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap.
-
Pre-registering a personal experiment, seriously Replied, post #72 · Research Methods › N-of-1 designs · 1 Jun 2025 · 22 likes Everything in post #69 holds. The case it does not cover is the one I have. It does not tell you about anybody else, which is why aggregating these accounts does not…
-
Price changes over 2025 and 2026, tabulated and dated Started this topic · Access › Pricing · 23 May 2025 · 5 likes Posting this under the heading it deserves: Price changes over 2025 and 2026, tabulated and dated Everything below is what sits behind that. Documenting an access…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #57 · Compounds › Tirzepatide · 20 May 2025 · 8 likes What I can speak to on GIP component of tirzepatide is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #115 · Evidence › Journal club · 12 May 2025 · 0 likes Post #113 put the caveat in the right place and I want to underline it. Worth stating the null on SURMOUNT-1 before we explain it: the observation may be nothing. That…
-
Foaming during reconstitution and whether it matters Replied, post #12 · Practice › Reconstitution · 11 May 2025 · 4 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. What I can speak to on foaming during reconstitution is narrow, so…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #85 · Evidence › Journal club · 21 Apr 2025 · 28 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #64 · Evidence › Journal club · 20 Apr 2025 · 1 like Offering a way to settle STEP 1 rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
-
Reading order for a first week here, and what to skip until later Replied, post #88 · Start Here › Welcome · 18 Apr 2025 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Adjudicated events and why the definition matters — the long version Replied, post #86 · Evidence › Trials · 7 Apr 2025 · 12 likes Picking up post #83: that is the part I would want checked first. Absolute and relative effects answer different questions. Write down the event rate in each arm and…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #109 · Compounds › Cagrilintide & amylin analogues · 4 Apr 2025 · 2 likes That is clearer than the version I had in my head. Thank you.
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #46 · Sourcing › Vendor reports · 2 Apr 2025 · 4 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #82 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 0 likes Taking post #79 at face value and following it one step further. Combination products complicate the certificate question considerably. Two active components mean two…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #58 · Compounds › Semaglutide · 30 Mar 2025 · 18 likes Practical note on SELECT: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #149 · Sourcing › Vendor reports · 19 Mar 2025 · 8 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #33 · Practice › Reconstitution · 17 Mar 2025 · 0 likes Coming back to post #32, because the follow-up matters more than the original answer. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #74 · Analytics › COA interpretation · 12 Mar 2025 · 0 likes Two claims get bundled together under Counter-ion form and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
Distinguishing a deletion sequence by mass alone Replied, post #96 · Analytics › Mass spectrometry · 16 Feb 2025 · 24 likes Coming back to post #92, because the follow-up matters more than the original answer. Calibration matters: a high-resolution instrument out of calibration can report…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #91 · Data & Tools › Calculators · 15 Feb 2025 · 4 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
-
Books and papers worth reading that are not about this at all Replied, post #11 · Lounge › Off topic · 5 Jan 2025 · 0 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. The honest answer is…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #27 · Safety › Adverse events · 21 Dec 2024 · 23 likes Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the site.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #86 · Practice › Side effects · 19 Dec 2024 · 2 likes Building on post #83 rather than restating it. I have been on both sides of the injection-site reactions argument in this category within eighteen months, which should…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #125 · Practice › Dosing & titration · 13 Dec 2024 · 29 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #16 · Sourcing › Vendor reports · 10 Dec 2024 · 33 likes Adding the measurement that post #13 says would settle it. Posting my vendor pages link the storefront numbers with the method attached so they can be discounted…
-
What we do not know about retatrutide, listed explicitly Replied, post #12 · Compounds › Retatrutide · 4 Dec 2024 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #84 · Compounds › Repair & healing peptides · 18 Nov 2024 · 2 likes Answering the question post #80 raises rather than the one it answers. One caution on reading a preclinical wound-healing model: everything above assumes the underlying…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #3 · Nutrition & Training › Protein & intake · 12 Nov 2024 · 0 likes Building on post #2 rather than restating it. The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more protein" ignores…
-
Identical chromatograms across two different lots Replied, post #39 · Sourcing › Red flags · 20 Oct 2024 · 23 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #14 · Sourcing › Regulatory · 20 Oct 2024 · 26 likes Research-use-only material is not approved for human use anywhere. That is a statement about the material's regulatory category rather than about its quality. Reading…
-
About the International category Replied, post #4 · Access › International · 7 Oct 2024 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Pen wastage and its effect on real cost Replied, post #32 · Access › Pricing · 7 Oct 2024 · 2 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #59 · Clinical › Bloodwork · 26 Sep 2024 · 0 likes Post #56 is the version of this I will quote in future. One addition. Bringing the actual numbers with intervals to an appointment is far more useful than describing…
-
Progressive overload when the scale is falling — one year on Replied, post #78 · Nutrition & Training › Resistance training · 21 Sep 2024 · 0 likes Post #74 put the caveat in the right place and I want to underline it. Progressive overload has been discussed here with more heat than it deserves, mostly because two…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #32 · Analytics › COA interpretation · 20 Aug 2024 · 14 likes Post #30 put the caveat in the right place and I want to underline it. What I would want before treating field-by-field walk through a certificate as settled: the…
-
Assessing a warm arrival: the decision process — one year on Replied, post #122 · Sourcing › Logistics · 2 Jun 2024 · 17 likes Coming back to post #120, because the follow-up matters more than the original answer. Import restrictions by jurisdiction: what is legal to import for personal use…